Skin Basal Cell Carcinoma — Trials

Skin Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 11
Ph III recruiting: 2
Growth YoY: —
Industry share: 29%
Top sponsor: University of Rochester
Termination share: 10%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07144384	Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma	completed	Early Phase 1	4	Ohio State University Comprehensive Cancer CenterOTHER	1	Sep 28, 2026	clinicaltrials
NCT02699723	Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer	withdrawn	Early Phase 1	0	Jean Yuh TangOTHER	0	Oct 22, 2020